SPRING VALLEY, N.Y., Jan. 31 /PRNewswire-FirstCall/ --Par Pharmaceutical Companies, Inc. will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 7, at 4:00 pm EST at The Grand Hyatt Hotel in New York City.
The audio-only live webcast will be accessible through the Merrill Lynch website at http://www.wsw.com/webcast/ml53/pki/ or through the Par Pharmaceutical website http://www.parpharm.com. A replay will be available at the same link address for 14 days after the conference, and will begin within 24 hours after the presentation.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In 2005, Par received approval for and introduced Megace(R) ES, its first branded pharmaceutical product, and expects to launch its second in 2006. Par’s Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par manufactures, markets or licenses more than 100 generic drugs. For press release and other company information, visit http://www.parpharm.com.
Par Pharmaceutical Companies, Inc.
CONTACT: Stephen J. Mock or Cecelia C. Heer, both of Par PharmaceuticalCompanies, Inc., +1-201-802-4000
Web site: http://www.parpharm.com/
